Independent. Not owned by or funded by any pharmaceutical manufacturer.
Evidence-sourced · medically-reviewed where indicated
Legal

Advertising and affiliate disclosure

Effective 2026-07-24 · Made under the FTC’s Endorsement Guides, 16 CFR Part 255

Current status: none of it

As of 2026-07-24, GLP-1 Healthcare runs no advertising, accepts no sponsorship, and earns no affiliate or referral commission from any provider listed on this site. Nothing you read here has been paid for by anyone.

Every commercial relationship, stated

Verified against the site as built on 2026-07-24. If any row changes to “Yes,” this table changes in the same release.
Commercial arrangementIn place?
Display or programmatic advertisingNo
Affiliate or referral commission on provider linksNo
Sponsored posts or paid placementsNo
Payment from any pharmaceutical manufacturerNo
Payment from any telehealth provider or pharmacyNo
Free products, services, or account access in exchange for coverageNo
Paid links or sold do-follow linksNo

Why this matters more here than on most sites

GLP-1 medications are an enormous commercial market, and most content ranking for these searches is monetised through exactly the arrangements listed above — usually through a “best of” list whose order tracks commission rates rather than evidence. Our provider directory is deliberately unranked and grouped by access model, and our match tool sorts only against criteria you choose. Neither can be bought into.

The standard we will hold to if this changes

We may eventually need revenue to sustain this work. If we do, these commitments come first and are not negotiable:

What we do link to

We link out constantly — to the FDA, DailyMed, medical journals, and to provider websites so you can check their terms yourself. None of those links are compensated. Outbound links to commercial sites carry rel="nofollow" so that our linking cannot be interpreted as an endorsement or traded for value.

Related

Full funding position: How We’re Funded. Editorial independence and our review process: Editorial Policy. Questions or a suspected undisclosed relationship: hello@glp1.healthcare.